Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

TheraSphere for the Treatment of Liver Metastases: An Open Label Trial of TheraSphere in Patients With Liver Metastases From Primary Colorectal Cancer, Neuroendocrine Cancer or Non-colorectal/Non-neuroendocrine Cancer

NCT00511862 is registered in ClinicalTrials.gov with Boston Scientific Corporation as lead sponsor.

NCT NCT00511862
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00511862 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
TheraSphere for the Treatment of Liver Metastases: An Open Label Trial of TheraSphere in Patients With Liver Metastases From Primary Colorectal Cancer, Neuroendocrine Cancer or Non-colorectal/Non-neuroendocrine Cancer
Lead sponsor
Boston Scientific Corporation
Phase
Phase 2
Overall status
Completed
Start date
January 31, 2007
Completion date
March 31, 2011
Enrollment
151 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

carcinoma, neuroendocrine, colorectal cancer, neoplasm metastasis